Warhound, a new defense technology company conceived by American technology entrepreneurs Ben Lamm and Palmer Luckey emerged from stealth ...

The average one-year price target for Myriad Genetics (NASDAQGS:MYGN) (DB:MYD) has been revised to $4.58 / share. This is an increase of 33.29% from the prior estimate of $3.43 dated September 29, ...

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support ...

To address oversupply and drive category growth, Divine Flavor leverages high-flavor varieties and a multi-region supply ...

Yield alone no longer defines commercial success, as the winning formula requires an integrated balance only provided by ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, ...

SALT LAKE CITY and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) ...

Russian President Vladimir Putin has made another controversial statement regarding the conflict around Ukraine, the status ...

Vylor (NYSE: VYLR), an advanced seed and genetics company, announced today it completed its separation from Corteva Inc., into an independent, publicly traded company and will begin trading later ...

James Peterson discusses driving the century-old berry grower forward by pairing high-tech quality control and proprietary ...

Opus Genetics , a, North Carolina-based clinical-stage biopharmaceutical company developing gene therapies for inherited ...

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) announce a collaboration to advance new prostate ...